Categories
Archives
- 2026
- 2025
- 2024
- 2023
Aug
05
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
Jul
07
UCB Awards Annual Myasthenia Gravis Scholarships to 15 Individuals Impacted by MG in the U.S.
Jun
17
UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)
Jun
04
Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps
Jun
03
Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis
Jun
01
UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa and Immediate Family Members
May
19
BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in psoriatic arthritis: BE BOLD Week 16 data
May
14
UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States
May
04
UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers